Ελληνικά
School of Medicine
University of Patras
>University of Patras
HQA
Personel - DAOUSIS DI.
  1. Home
  3. Personel
  5. Associate Professors

DAOUSIS DIMITRIOS, Associate Professor

DAOUSIS DIMITRIOS

Sector: Division of Internal Medicine Ι

Clinic/Laboratory: Department of Internal Medicine

Knowledge Subject:

Research Area: The role of B cells in the pathogenesis of fibrosis. Mechanisms of bone and joint remodelling in rheumatic diseases.

University Hospital of Patras Rion, Patras, Greece 26504 Department of Internal Medicine, Division of Rheumatology

2613 603693 2610 993982 daoussis@upatras.gr

Download Curriculum Vitae

Summary of Curriculum Vitae

Place and date of birth: 12th September 1972, Ontario, Canada
 
I graduated from the Medical School of Patras University on 1996.  I completed my training in Rheumatology in Patras University Hospital on 2005.  I worked as a Consultant in Rheumatology (Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Birmingham, UK) from Jan 2006 to Nov 2006.  I was awarded Ph.D from the Medical School of Patras University on 2006.  I worked as a Consultant in Rheumatology in Patras University Hospital from 2006 to 2009.  I am currently working as a Lecturer of Internal Medicine/Rheumatology in Patras University Hospital.
My main research interests are i) the role of B cells in the pathogenesis of fibrosis in Systemic Sclerosis and ii) mechanisms of bone and joint remodelling in rheumatic diseases.
 

Undergraduate Courses

Selected Publications

  1. Daoussis D, Andonopoulos AP, Liossis SN. Targeting CD40L: a promising therapeutic approach. Clinical and Diagnostic Laboratory Immunology. 2004 Jul; 11(4): 635-41
  2. Daoussis D, Antonopoulos I, Andonopoulos AP, Liossis SN. Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis. Rheumatology (Oxford). 2007 Feb;46(2):227-31.
  3. Daoussis D, Andonopoulos AP, Liossis SN. Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. Seminars in Arthritis and Rheumatism. 2010 Apr;39:369-83.
  4. Daoussis D, Panoulas VF, Antonopoulos I, John H, Toms TE, Wong P, Nightingale P, Douglas KM, Kitas GD. Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 2010 Mar;69:517-21.
  5. Daoussis D, Liossis SN, Tsamandas AC, Kalogeropoulou C, Kazantzi A, Sirinian C, Karampetsou M, Yiannopoulos G, Andonopoulos AP. Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology (Oxford). 2010 Feb;49:271-80.
  6. Daoussis D, Panoulas V, Toms T, John H, Antonopoulos I, Nightingale P, Douglas KM, Klocke R, Kitas GD. Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Research & Therary. 2009;11(4):R116.
  7. Daoussis D, Liossis SN, Tsamandas AC, Kalogeropoulou C, Kazantzi A, Korfiatis P, Yiannopoulos G, Andonopoulos AP. Is there a role for B cell depletion as therapy for scleroderma? A case report and review of the literature. Seminars in Arthritis & Rheumatism. Epub ahead of print
  8. Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, Yiannopoulos G, Andonopoulos AP. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis & Rheumatism. 2010 Jan;62(1):150-8.
  9. Daoussis D, Kitas GD. Uric acid and cardiovascular risk in rheumatoid arthritis. Rheumatology. 2010 Epub ahead of print